BioHarvest Sciences Inc. (BHST) Reports Q3 Loss, Misses Revenue Estimates
BioHarvest Sciences Inc. (BHST) came out with a quarterly loss of $0.16 per share versus the Zacks Consensus Estimate of a loss of $0.05. This compares to break-even earnings per share a year ago.
BioHarvest Sciences reports increased revenues, profits for Q3
BioHarvest Sciences Inc. (CSE:BHSC, OTC:CNVCF) reported robust financial performance for the third quarter ending September 30, 2024. The company achieved a 101% year-over-year revenue increase to $6.5 million, surpassing management's guidance.
BioHarvest Sciences launches VINIA SuperFood Teas
BioHarvest Sciences Inc. (CSE:BHSC, OTC:CNVCF) has expanded its product offerings with the launch of VINIA SuperFood Functional Teas, marking a strategic move into the $3.3 billion North American functional tea market. The new line features four premium blends: Black Tea, Green Tea, Matcha Green Tea, and Cranberry Hibiscus Herbal Tea, each infused with piceid resveratrol, the active ingredient from the company's clinically validated VINIA supplements.
